United States · FDA National Drug Code directory

Fenofibric Acid

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62332-244_fdb85004-0a66-487a-992c-61764da679b4
Product NDC
62332-244
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Fenofibric Acid
Labeler
Alembic Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20170515
Source listing expiry
20261231

Source-listed ingredients

  • FENOFIBRIC ACID — 45 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-30) · 62332-244-30
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-90) · 62332-244-90
  • 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-91) · 62332-244-91

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →